Webinars

Breakthroughs in Alzheimer’s Disease Assessment: Quantitation of CSF Beta Amyloid 40 & 42

Author: Clarke, Nigel J., PhD
Date: Wednesday, June 14, 2017
Category: For Credit, Webinar
Description: Dr Clarke discusses the advantages in assessing Alzheimer’s disease by measurement of amyloid beta 42/40 ratio, describes an improved LC-MS/MS approach for quantitating amyloid beta... Read more 

Assessment and Management of Rapidly Progressive Dementia (RPD)

Author: Geschwind, Michael D., MD, PhD
Date: Monday, June 12, 2017
Category: For Credit, Webinar
Description: Dr Geschwind discusses when to consider a diagnosis, the differential diagnoses, proper evaluation, and reviews the various management strategies for RPD.

At... Read more 

Why the HCV Genotyping Test is Still Needed in the Era of Pan-Genotypic Drugs

Author: Reau, Nancy, MD
Date: Monday, June 12, 2017
Category: Webinar
Description: Dr Nancy Reau discusses why genotyping is still needed.

At the conclusion of this program, participants will be able to:
-Illustrate... Read more 

Insights into the Importance of Genetic Testing in Epilepsy

Author: Smith, Lacey, MS, CGC
Date: Monday, June 12, 2017
Category: Webinar
Description: Lacy Smith, genetic counselor with Boston Children’s Hospital’s Epilepsy Genetics Program and Athena Diagnostics’ genetic counselor Susan Hahn describes the etiology of epilepsy, and the... Read more 

Use of FibroTest® (Noninvasive) to Assess Liver Fibrosis in Place of Biopsy

Author: Alam, Imtiaz, MD
Date: Wednesday, May 17, 2017
Category: Webinar
Description: Dr Alam explains why noninvasive tests are an alternative to liver biopsy. Read more 

Black Box Warning: Hepatitis B Testing for Patients on Hepatitis C Direct Acting Antivirals

Author: Feld, Jordan, MD, MPH
Date: Tuesday, May 16, 2017
Category: Webinar
Description: Dr Jordan Feld, MD, MPH, explains the testing associated with black box warning and why additional testing is needed.

Read more 

True or False? Presumptive Drug Testing

Author: McClure, F. Leland, MSci, PhD, F-ABFT
Date: Thursday, April 20, 2017
Category: Webinar
Description: Dr. McClure describes presumptive drug testing, how to interpret presumptive test results, and discusses appropriate follow-up actions for presumptive drug testing.

At... Read more 

Quantitative HBsAg and its Role in Chronic Hepatitis B Patient Management

Author: Gish, Robert, MD
Date: Friday, April 07, 2017
Category: For Credit, Webinar
Description: Dr Gish explains how HBsAg Quantitative test can be used to phase disease and manage treatment of Hep B positive patients, discusses the testing for... Read more 

Tuberculosis Screening: Latest Developments in Diagnostic Testing

Author: Qasba, Sarojini Sonia, MD, MPH
Date: Monday, March 27, 2017
Category: For Credit, Webinar
Description: Dr. Qasba describes latent tuberculosis infection (LTBI) and identifies appropriate patients to be tested, discusses recently updated clinical practice guidelines for diagnosis of tuberculosis (TB)... Read more 

Blueprint for Athletes: Case Studies from Ronnie Barnes, Sr. VP and Head Athletic Trainer, New York Football Giants

Author: Barnes, Ronnie
Date: Friday, March 03, 2017
Category: Webinar
Description: Ronnie Barnes, Senior Vice President and Head Athletic Trainer, New York Football Giants, discusses the high physical demands of athletes and the value of implementing... Read more